Hematologic changes after splenectomy for ovarian cancer debulking surgery, and association with infection and venous thromboembolism

Introduction The spleen plays a role in the immune and coagulative responses, yet a splenectomy may be required during ovarian cancer surgery to achieve complete cytoreduction. The aim of the study was to correlate hematologic changes with the development of infection and venous thromboembolism in patients undergoing splenectomy. Methods This single-institution retrospective review includes all patients undergoing splenectomy during cytoreductive surgery for advanced ovarian cancer, March 2001 to December 2016. We compared postoperative hematologic changes (evaluated daily before discharge) in patients developing infection within 30 days' post-surgery (Infection group) with those who did not (No-Infection group). We also compared patients developing venous thromboembolism with those without. Results A total of 265 patients underwent splenectomy. Median age was 64 years (range 22–88): 146 (55%) patients had stage IIIC and 114 (43%) patients had stage IV. The majority, 201 (76%) patients underwent splenectomy during primary debulking. A total of 132 (50%) patients comprised the Infection group (most common: urinary tract infection, 54%). Median time from surgery to infection was 8 days (range, 0–29). After initial rise in white blood cell count in both groups, the Infection group had a second peak on postoperative day 10 (median 16.6K/mcL, IQR 12.5–21.2) not seen in the No-Infection group (median 12K/mcL, IQR 9.3–16.3). A total of 40 (15%) patients developed venous thromboembolism, median time of 6.5 days (range, 1–43). All patients demonstrated a continuous rise in platelets during postoperative days 0–15. Thrombocytosis was present in 38/40 (95%) patients with venous thromboembolism vs 183/225 (81%) patients without (P=0.036). Median days with thrombocytosis was higher in venous thromboembolism (8 days, range 1–15) vs non groups (6 days, range 1–16, P=0.049). Conclusion We identified initial leukocytosis after splenectomy in all patients. The Infection group had a second peak in white blood cell count on postoperative day 10, not present in the No-Infection group. Among patients with venous thromboembolism, thrombocytosis was more frequent and of longer duration.

[1]  Qingjian Ye,et al.  Association of pretreatment thrombocytosis with prognosis in ovarian cancer: a systematic review and meta-analysis , 2018, Journal of gynecologic oncology.

[2]  M. Schreiber,et al.  Splenectomy is associated with higher infection and pneumonia rates among trauma laparotomy patients. , 2017, American journal of surgery.

[3]  Eric J. Ley,et al.  Splenectomy is associated with a higher risk for venous thromboembolism: A prospective cohort study. , 2015, International journal of surgery.

[4]  I. Fournel,et al.  Diagnostic accuracy of inflammatory markers as early predictors of infection after elective colorectal surgery: results from the IMACORS study , 2015 .

[5]  M. Cohen,et al.  Splenectomy is associated with hypercoagulable thrombelastography values and increased risk of thromboembolism. , 2015, Surgery.

[6]  Alexander W. Lamb,et al.  Postoperative infection risk after splenectomy: A prospective cohort study. , 2015, International journal of surgery.

[7]  M. Adamina,et al.  Meta‐analysis of the predictive value of C‐reactive protein for infectious complications in abdominal surgery , 2015, The British journal of surgery.

[8]  J. Claridge,et al.  Diagnosis of infection after splenectomy for trauma should be based on lack of platelets rather than white blood cell count. , 2014, Surgical infections.

[9]  E. Weledji Benefits and risks of splenectomy. , 2014, International journal of surgery.

[10]  D. Farkas,et al.  Risk of venous thromboembolism in splenectomized patients compared with the general population and appendectomized patients: a 10‐year nationwide cohort study , 2010, Journal of thrombosis and haemostasis : JTH.

[11]  M. Schreiber,et al.  Splenectomy leads to a persistent hypercoagulable state after trauma. , 2010, American journal of surgery.

[12]  S. Cha,et al.  Splenectomy as part of cytoreductive surgery in ovarian cancer. , 2006, Gynecologic oncology.

[13]  T. Krivak,et al.  Hematologic changes after splenectomy for cytoreduction: implications for predicting infection and effects on chemotherapy , 2006, International Journal of Gynecologic Cancer.

[14]  N. Spirtos,et al.  Splenectomy in the context of primary cytoreductive operations for advanced epithelial ovarian cancer. , 2006, Gynecologic oncology.

[15]  P. Rhee,et al.  White blood cell and platelet counts can be used to differentiate between infection and the normal response after splenectomy for trauma: prospective validation. , 2005, The Journal of trauma.

[16]  M. Gonen,et al.  Interaction of splenectomy and perioperative blood transfusions on prognosis of patients with proximal gastric and gastroesophageal junction cancer. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  G. Velmahos,et al.  Leukocytosis after posttraumatic splenectomy: a physiologic event or sign of sepsis? , 2002, Archives of surgery.

[18]  S. Brotman,et al.  Postsplenectomy leukocystosis: physiologic or an indicator of infection? , 1992, The American surgeon.